Introduction
Preeclampsia is a severe obstetric disorder aVecting about 2-7% of pregnant women [1, 2] . Its features include high blood pressure, proteinuria and edema [1] . This disorder is associated with a considerable risk for feto-maternal morbidity and mortality [3] . Recent research has indicated that these diverse arrays of symptoms may be the result of an excessive maternal systemic inXammatory response to pregnancy, involving activation of the innate immune system and damage of the maternal endothelial compartment [3, 4] .
It is well established that the placenta plays a central role in the underlying etiology of preeclampsia and it has been suggested that the elevated release of syncytiotrophoblast derived micro-particles (STBM) may contribute to this pathology, which aVects both the maternal endovasculature and immune systems [2, 4, 5] . In normal pregnancy, trophoblast cells and STBM are spontaneously released from the placenta as a sign of normal placental physiologic turnover [6] [7] [8] . This phenomenon has been associated with the mild inXammatory state accompanying pregnancy [3, 9] . This proposal is supported by the observations that STBM are shed in greater quantities by the placenta in preeclampsia and that STBM generated in vitro by mechanical dissection of the placenta suppresses endothelial cell proliferation [10] . This increased shedding of sub-cellular material parallels the raise in circulating cell-free fetal DNA [11, 12] , demonstrating the increased placental dysfunction associated with the disorder [13] . Therefore, it has been proposed that the increased shedding of STBM into the maternal blood of women with preeclampsia could be responsible for the manifest dysfunction of the vascular endothelium [9] .
In order to study the eVect of STBM in greater detail, recently we have characterized three diVerent STBM preparations [14] . The eVects of three STBM preparations were examined on endothelial cells and puriWed T cells [14, 15] . Among the three STBM preparations, mechanically derived STBM (mSTBM) preparation largely behaved in a diVerent manner than the other two preparations, i.e. villous explants STBM (vSTBM) and placental perfusion STBM (pSTBM) [14] . We observed that only mSTBM signiWcantly inhibited endothelial cell proliferation and induced apoptosis of these cells [14] .
It has been proposed that preeclampsia and atherosclerosis share similar symptoms [16] [17] [18] . In this regard lipids have been shown to play an important role in the pathogenesis of both diseases [16] [17] [18] . As STBM are the products of syncytiotrophoblast cell layer of the villous tree, they should contain membrane lipids, which might play a role in the pathogenesis of preeclampsia. Therefore, in this study, we examined lipids levels in diVerent STBM preparations. Moreover, lipid levels could be reduced from the STBM preparations and the eVects of these various STBM preparations were examined on endothelial cell proliferation and apoptosis.
Materials and methods

Preparation of syncytiotrophoblast micro-particles
This study was approved by the Cantonal Institutional Review Board of Basel, Switzerland. Written informed consent was requested in all instances. Placentae and umbilical cords were obtained after normal term delivery or elective cesarean section from uncomplicated pregnancies and processed within 30-90 min of collection. STBM were prepared by three diVerent methods as described previously [14] . The protein content in each STBM preparation was quantiWed with the advanced protein assay reagent (Cytoskeleton Inc. Denver, CO, USA) according to the manufacturer's instructions.
Lipid analysis of STBM
One hundred micrograms of the each STBM preparation was extracted with chloroform. After centrifugation for 1 min the lipid containing lower organic layer was collected and applied to the pre-coated thin layer chromatography (TLC) plate. TLC was carried out in the pre-saturated chamber. The running buVer consisted of chloroform:methanol:water:ammonium hydroxide 65:30:3:2 (v/v/v/v). The TLC run was monitored until the top of the plate. The separated lipids were visualized by staining with mosatin stain [4% ammonium molybdate tetrahydrate (w/v) + 0.08% cesium sulfate tetrahydrate (w/v) + 30% H 2 SO 4 (10%, v/v)] and charring at 200°C.
Lipid reduction from STBM
One hundred micrograms of the each STBM preparation was incubated with varying concentrations (2-8%) of methyl--cyclodextrin (M CD) at RT for 30 min. After incubation with M CD STBM were pelleted down and resuspended in sterile phosphate buVered saline (PBS). Lipids were extracted from M CD treated STBM and the supernatants as described above. TLC was carried out to conWrm the lipid reduction from the STBM preparations and their appearance in the supernatants.
Cell proliferation assay
Human umbilical vein endothelial cells were isolated from normal term human umbilical cord by the method described by JaVe et al. [19, 20] and stored in liquid nitrogen until use. Cells from passage 2 to 7 were used for all experiments. HUVEC proliferation was measured using cell proliferation kit (Roche Diagnostics, Basel, Switzerland), which measures BrdU incorporation during DNA synthesis. In brief, 1.5 £ 10 4 cells were plated onto 1% gelatin coated 96 well microtiter plates (Nunc, Denmark) in endothelial serum-free medium (E-SFM) supplemented with 20 ng/ml human recombinant basic Wbroblast growth factor (bFGF) and 10 ng/ml human recombinant epidermal growth factor (EGF) (GIBCO Invitrogen Life Technologies, Grand Island, NY, USA). After 6 h, the culture medium was replaced with untreated STBM or M CD treated STBM diluted in DMEM:F12 medium supplemented with 1% antimycotic/antibiotics, 10% FCS, 50 U/ml aprotinin, 25 U/ ml heparin (DMEM:F12 complete medium). The cells were then incubated for 22 h, followed by an additional incubation with 10 M of BrdU for a further 18 h. The amount of incorporated BrdU was detected using an ELISA reader (Molecular Devices, Sunnyvale, CA, USA) according to the manufacturer's instructions.
Human umbilical vein endothelial cells apoptosis
Apoptosis was measured using a commercial cellular DNA fragmentation ELISA kit (Roche Diagnostics, Germany).
This assay measures the release of BrdU labeled DNA fragments into the cytoplasm during apoptosis. In brief, 2 £ 10 4 HUVEC were plated in 96 well microtiter plates (Nunc, Denmark) in E-SFM culture medium supplemented with 20 ng/ml bFGF and 10 ng/ml EGF. After 6 h 10 M BrdU was added and incubated for a further 18 h. Following BrdU labeling, the cell monolayer was washed with sterile PBS, then M CD treated and untreated STBM containing DMEM:F12 complete medium was added for 24 h. In positive control wells, apoptosis was induced with 5 M staurosporine (Sigma Chemicals, St Louis, MO, USA), a potent inducer of apoptosis, for 3 h. The detection of BrdU labeled apoptotic DNA fragments was performed according to the manufacturer's instructions.
Results
Mechanical STBM were rich in lipids
All three STBM preparations were applied to TLC plate after the lipid extraction as described in "Materials and methods". Five spots were observed on the run front of the TLC plate. Using commercially available cholesterol as a standard, spot at the top of the TLC plate run was identiWed as cholesterol. This analysis also revealed that the lipid concentration in the mSTBM is greater than the other two STBM preparations (Fig. 1) . These data indicate the possibility of mSTBM to be richer in membrane materials than the other two STBM preparations at equal protein concentration.
Methyl--cyclodextrin eYciently reduced lipids from STBM It has been previously shown that membrane lipids can eYciently be depleted using M CD [21] . Therefore, we reduced lipids from all the three STBM preparations as described in "Materials and methods". In a dose-dependent manner large amounts of lipids could be reduced from mSTBM (Fig. 2a) . Moreover, the reduced lipids appeared in the supernatant of the treated mSTBM (Fig. 2a) . On the other hand, low levels of lipids present in pSTBM and vSTBM could be depleted by the lowest concentration of M CD (2%) (Fig. 2b) . These observations suggest that M CD could eVectively reduce membrane lipids in all three STBM preparations.
Lipid reduction from mechanically derived STBM reduced their potential to inhibit HUVEC proliferation It has been previously reported that the three STBM preparations can inhibit endothelial cell proliferation in a dose dependant manner [14] . Therefore, we examined whether the lipid depletion of the three diVerent STBM aVected HUVEC proliferation. The eVects of equal amounts of normal and lipid depleted STBM, as determined by protein content, were compared on HUVEC proliferation. For this analysis we made use of highest concentration (12 g/well) of each STBM preparation as this dose has previously been shown to inhibit maximal HUVEC proliferation [14] . We observed that upon lipid reduction the inhibition of HUVEC proliferation by mSTBM (90% at 12 g untreated Fig. 1 Thin layer chromatographic analysis of diVerent STBM preparations. Lipids were extracted from 100 g of the each STBM preparation as described in "Materials and methods" and applied to the precoated TLC plate. TLC was carried out in the pre-saturated chamber. The TLC run was monitored until the top of the plate. The separated lipids were visualized after staining. This analysis revealed Wve lipid spots in all STBM preparations. This analysis also conWrmed that the mSTBM are rich in membrane lipids Fig. 2 Lipid reduction in diVerent STBM preparations. One hundred micrograms of the each STBM preparation was incubated with varying doses of M CD for 30 min and then lipids were extracted as described in "Materials and methods". Lipids were also extracted from the supernatants of M CD treated STBM. Treated and untreated STBM were applied to the pre-coated TLC plate. TLC was carried out in the presaturated chamber. This analysis revealed that lipids from mSTBM could eYciently be reduced in the dose-dependant manner and depleted lipids could be observed in the supernatant (a). On the other hand, lipids from pSTBM and vSTBM could be depleted totally with the lowest concentration (2%) of M CD (b) mSTBM per well) was signiWcantly reduced (58% at 12 g M CD treated mSTBM per well). On the other hand, lipid depletion of the villous explants STBM and placental perfusion STBM, at similar dose, did not lead to a decrease in the inhibition of endothelial cell proliferation (Fig. 3) .
Lipid reduction from mechanically derived STBM abolished their potential to induce HUVEC apoptosis
We have previously reported that among the three STBM preparations only mSTBM induced HUVEC apoptosis in a dose-dependant manner [14] . Therefore, we examined whether lipid depletion of mSTBM reduced their potential to induce apoptosis in HUVEC. We observed that the apoptosis induced by mSTBM at highest concentration, 28% apoptosis at 12 g untreated mSTBM per well, could be abolished after lipid reduction in this STBM preparation when used at similar dose (Fig. 4) .
Discussion
In this study, we extend upon previous study in which three diVerent STBM preparations were characterized morphologically and functionally [14] . Now, we have examined lipid levels in these STBM preparations using TLC. In this regard it has been previously reported that high lipid content leads to endothelial cell dysfunction in many diseases such as hypercholesterolemia, preeclampsia, inXammation and hypertension [18, 22] . Our TLC analysis of the three STBM preparations revealed mSTBM has the highest lipids content, when compared to the other two STBM preparations. As STBM are derived from the syncytiotrophoblast membrane layer of the placenta, it is most likely that the lipids present in these STBM preparations are of membrane origin. Large amounts of lipids present in mSTBM indicate the high levels of membranous material present in this preparation, which is in agreement with our previous observation where mSTBM contains large amounts of GPI, anchored lipid membrane enzyme, placental like alkaline phosphatase (PLAP) [14] .
Three STBM preparations have been shown to reduce HUVEC proliferation, among them mSTBM had the greatest eVect and induced endothelial cell death by apoptosis [14] . As this functional disparity of the STBM on endothelial cell culture was not clear at that time, we examined whether this eVect is due to the excess lipid content present in mSTBM. For this purpose we reduced lipids from the three STBM preparations using M CD. We observed that lipid decrease in the STBM preparations resulted in the reduced inhibition of HUVEC proliferation by mSTBM. No similar eVects were noticed with the other two STBM preparations. Moreover, lipid reduction in mSTBM blocked their potential to induce apoptosis. Hence, these observations provide further evidence that the three STBM diVer in their biochemical composition as well. As the extent of HUVEC proliferation inhibition by lipid-depleted mSTBM was similar to that mediated by pSTBM or vSTBM in their native form, suggesting that lipids contribute partially to the inhibition of HUVEC proliferation and subsequent apoptosis. Therefore, these data suggest that excessive HUVEC proliferation inhibition and apoptosis induction mediated by the mSTBM in its native form may be due to the high levels of lipids present in these particles. It has been suggested that in vivo the shedding of placental particles is a continuous feature of normal pregnancy, which increases during pregnancy due to an increase in placental size. In this context, it has been proposed the vSTBM and pSTBM prepared from explants cultures or placental perfusion, respectively, may more closely mimic micro-particles released by normal syncytiotrophoblast turnover [23] . On the other hand mSTBM, which are generated by mechanical disruption of villous integrity, may be more similar to particles released by the process of aponecrosis, which have been proposed to occur in the preeclamptic placentae due to oxidative stress [23] . Therefore, it will be interesting to examine in future whether STBM from preeclamptic patients exhibit higher levels of lipids akin to what we have observed in mSTBM.
